|
US2020352927A1
|
|
Methods of treatment of asthma and COPD
|
|
US2020268734A1
|
|
Methods of treatment of respiratory disorders
|
|
WO2016200578A1
|
|
Methods of treatment of non-histaminic pruritus in mammals
|
|
US2016228426A1
|
|
Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients
|
|
US2017105987A1
|
|
Formulations and methods for treating high intraocular pressure
|
|
US2015272942A1
|
|
Methods of treatment of non-histaminic pruritus
|
|
US2015272941A1
|
|
Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen
|
|
US2015045392A1
|
|
Methods of treatment of histamine H-4 receptor-related pruritus
|
|
US2014120121A1
|
|
Medicinal treatment of atopic inflammatory diseases
|
|
US8557846B1
|
|
Medicinal treatment of dermal diseases in dogs
|
|
US2011218218A1
|
|
Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain
|
|
WO2010047681A1
|
|
Treating xerophthalmia with norketotifen
|
|
WO2009073051A1
|
|
Use of rr/sr-ractopamine
|
|
WO2008088756A1
|
|
Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus
|
|
WO2008011161A2
|
|
Dermal anesthetic compounds
|
|
US2007282010A1
|
|
Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals
|
|
US2009137628A1
|
|
Formulations of Indanylamines and the Use Thereof as Local Anesthetics and as Medication for Chronic Pain
|
|
US2006293356A1
|
|
Methods for treating urinary incontinence in patients suffering from memory disorders
|
|
US2006079558A1
|
|
R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
|
|
WO2006036936A2
|
|
The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
|
